Molecular Design of Compounds Targeting Histone Methyltransferases

Alberto Del Rio, Greta Varchi

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Research on cancer epigenetics has flourished in the last decade as growing evidence points to the importance of understanding the mechanisms by which epigenetic changes regulate the genesis and progression of several pathologies, especially cancer. Several epigenetic targets have been discovered and are currently under validation for different therapies. In this context, drug discovery approaches aiming at developing new small-molecule modulators have produced the first preclinical and clinical outcomes and many other compounds are now entering the pipeline as new epi-drugs. While most of the efforts have been dedicated in the past to histone deacetylases and DNA methyltransferases, other classes of enzymes are also likely to represent new frontiers for therapeutic interventions. In this chapter we describe the increasing importance of histone methyltransferases in the drug discovery arena and discuss the drug design perspectives enabled by computational techniques to develop new small-molecule inhibitors for these classes of enzymes.

Original languageEnglish (US)
Title of host publicationEpi-Informatics
Subtitle of host publicationDiscovery and Development of Small Molecule Epigenetic Drugs and Probes
PublisherElsevier
Pages257-272
Number of pages16
ISBN (Electronic)9780128028094
ISBN (Print)9780128028087
DOIs
StatePublished - Apr 6 2016

Keywords

  • Anticancer therapy
  • Crystallography
  • Drug design
  • Epigenetics
  • Histone posttranslational modifications
  • Protein methyltransferases
  • Small-molecule inhibitors

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Fingerprint Dive into the research topics of 'Molecular Design of Compounds Targeting Histone Methyltransferases'. Together they form a unique fingerprint.

Cite this